medigraphic.com
ISSN 0188-9796 (Print)

2007, Number 2

<< Back Next >>

Rev Endocrinol Nutr 2007; 15 (2)

Localized myxedema

Gómez VE, Franco CJJ, Pérez HJL

Language: Spanish
References: 17
Page: 104-108
PDF size: 130.75 Kb.


ABSTRACT

Pretibial myxedema or localized myxedema due to accumulation of acid mucopolysacarides, is rare manifestation extrathyroidal of Graves disease. The authors reported a case of localized myxedema.


REFERENCES

  1. Kriss JP. Pathogenesis and treatment of myxedema pretibial. Endocrinol Metab Clin North Am 1987; 16: 409-415.

  2. Pérez-Polito A, Estrada R, Arenas R. Mixedema pretibial. Estudio de un caso. Dermatología Rev Méx 1990; 34: 215-219.

  3. Pachon-Burgos I. XLC Soc. Mexicana Nutrición y Endocrinología, Mérida Yucatán. 2005.

  4. Somach SC, Helm TN, Lawlor KB, Bergfeld WF, Bass J. Pretibial mucin. Histologic patterns and clinical correlation. Arch Dermat 1993; 129: 1152-1156.

  5. Smith TS. Myxedema pretibial. Cap. 31. pag: 676. In: The Thyroid. Braverman IE, Utinger RD. Sixth edition. 1996. J:B. Lippincott Company.

  6. Salvi M, De Chiara M, Gardine E, Minelli R, Bianconi L, Alinovi A, Ricci R, Neri F, Tost C, Roti E. Echographic diagnosis of pretibial myxedema in patients with autoimmune thyroid disease. Europ J Endocrinol 1994: 131: 113-119.

  7. Schwartz KM, Fatourechi V, Ahmed A, Pond GR. Dermopathy of Graves disease (Pretibial Myxedema): Long term outcome. J Clin Endocrinol Metab 2002; 87: 438-448.

  8. Saito S, Sakurada T, Yamamoto M, Yamaguchi T, Yoshida K. Exopthalmus-myxedema circumscriptum preatibiale-osteoarthropathia hypertrophicans (EMO) syndrome in Graves disease: a review of eight cases reportad in Japan. 1975; 115: 155-165.

  9. Chen JS, Ladenson PW. Euthyroid pretibial myxedema. Am J of Med 1987; 82: 318-319.

  10. Georgala S, Katoulis AC, Georgala C, Katoulis EC, Hatzololou E, Stavirianeas NG. Prefibial myxedema as the initial manifestation of Graves disease. Europ Acad Derma and Venerol 2002; 16: 380-383.

  11. Jabbour SA. Cutaneous manifestations of endocrine disorders. 2003; 4: 315-331.

  12. Wy SL, Chang TC, Chang TJ, Kuo YF, Hasiao YL, Chang CC. Cloning and sequencing of complete thyrotropin receptor transcripts in pretibial fibroblast culture cells. J Endocrinol Invest 1996; 19: 365-370.

  13. Fatourechi V. Localized myxedema and thyroid acropachy. Cap. 23 pag. 488. In Thyroid Braverman IE, Utiger RD. Ninth Edition 2005 J:B. Lippincott Company.

  14. Kriss JP, Pleshakov V, Rosenblum A. Therapy with occlusive dressings of pretibial myxedema with fluorcinolona acetonido. J Clin Endocrinol Metab 1967; 27: 595-604.

  15. Volden G. Successful treatment of chronic skin disease with clobetasol propionato and hydrocolloid occlusive dressing. Acta Derm Venereol 1992; 72: 67-71.

  16. Antonelli A, Navananne A, Mestrum C, Paella R, Alberti B, Socorreo A, Mestrum C, Roger P, Angosti S, Baseline L. Pretibial myxedema and high dose intravenose inmunoglobulin treatment. Thyroid 1994; 4: 339.408.

  17. Sussens WS, Hermans AG, Chapman MS, Baughamn RD. Elefantiasic pretibial myxedema: a novel treatment for un uncommon disorders. J Am Academ Dermatol 2002; 46(7): 23-26.




2020     |     www.medigraphic.com